Skip to Main Content

Paper Details

Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for Treatment of Anemia in Chronic Kidney Disease: A Placebo-Controlled Study of Pharmacokinetic and Pharmacodynamic Profiles in Hemodialysis Patients.
J Clin Pharmacol
15
2020
Author NameAffiliation
James A TumlinSoutheast Renal Research Institute
  • 1 - 1

Datasets

Release 1.2